REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 26 filers reported holding REGULUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 833 | -33.3% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 1,249 | +49.9% | 0.00% | – |
| Q1 2016 | $1,000 | – | 833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,985,472 | $3,097,000 | 1.60% |
| Endurant Capital Management LP | 2,376,557 | $3,707,000 | 0.97% |
| Sarissa Capital Management LP | 1,851,851 | $2,888,000 | 0.28% |
| NEA Management Company, LLC | 6,451,056 | $10,064,000 | 0.23% |
| Atom Investors LP | 337,228 | $526,000 | 0.09% |
| Ikarian Capital, LLC | 1,245,989 | $1,943,000 | 0.06% |
| GYL FINANCIAL SYNERGIES, LLC | 51,376 | $80,000 | 0.04% |
| Focused Wealth Management, Inc | 100,000 | $156,000 | 0.03% |
| Point72 Asset Management, L.P. | 3,215,436 | $5,016,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 141,629 | $221,000 | 0.01% |